oprah winfrey glp 1 special on How Weight Loss Gave Her ‘New Freedom’ @oprah Winfrey is one of

Additionally, several GLP-1 receptor agonists are being developed or repurposed for the treatment of alcohol, tobacco, and opioid use disorders

Many women also report improvements in hot flashes, sleep quality, and mental clarity

In the field of weight loss drug development, the recently disclosed clinical data of Amgens weight loss candidate drug Maridebart Cafraglutide (referred to as MariTide, formerly known as AMG 133) has drawn widespread attention in the industry and is considered a potential Game Changer. The reason why MariTide is seen as a game-changer in the weight loss drug market dominated by Wegovy and Zepbound is an important factor: MariTides molecular modality is a unique antibody-peptide conjugate (also known as Peptibody)

Not enough insurers signed on for the voluntary plan by the April deadline, so CMS instead announced it would extend the Bridge program to 18 months, with a new end date of December 2027